GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.

Researchers at UT Arlington have discovered a key enzyme, IDO1, that when blocked, helps immune cells regain their ability to properly process cholesterol—something that breaks down during ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

Heart attack survival odds have dramatically improved over the past 5 decades, but more people are dying from chronic cardiac ...

Lorundrostat, an aldosterone synthase inhibitor, effectively treated uncontrolled hypertension in Launch-HTN, researchers ...